• Oasmia launches the ovarian cancer treatment drug Apealea® in Sweden, Denmark and Finland

  • Oasmia and Elevar sign a global strategic partnership for the commercialization of Apealea®

  • Oasmia has released its Q3 report

  • Oasmia’s presentation at Avanza Börsdag on 3 June 2020

The Share